From GlobeNewswire: 2024-05-07 16:38:00

Vera Therapeutics, Inc. announced the granting of inducement awards, including stock options and RSUs, to new employees on May 1 and May 6, 2024, under their Inducement Plan. The stock options have exercise prices of $42.32 and $45.00 per share, respectively, with vesting over four years. The RSUs will also vest over four years, with 25% vesting on each anniversary of May 20, 2024, subject to continued service. Vera Therapeutics is a biotechnology company focused on developing treatments for immunological diseases, with a lead product candidate targeting autoimmune diseases like IgAN and lupus nephritis. Vera also has a monoclonal antibody in development for BK virus infection.

Investor Contact: Joyce Allaire, LifeSci Advisors, 212-915-2569, [email protected]
Media Contact: Mari Purpura, LifeSci Advisors, [email protected]



Read more at GlobeNewswire: Vera Therapeutics Reports Inducement Grants Under Nasdaq